C3ORF63 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.122400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.888360E-01
Normal-vs-Stage2
3.170200E-01
Normal-vs-Stage3
1.620200E-01
Normal-vs-Stage4
4.077800E-01
Stage1-vs-Stage2
6.952800E-01
Stage1-vs-Stage3
4.832500E-02
Stage1-vs-Stage4
4.921600E-01
Stage2-vs-Stage3
4.234400E-02
Stage2-vs-Stage4
2.624600E-01
Stage3-vs-Stage4
1.200110E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.186200E-01
Normal-vs-AfricanAmerican
1.714640E-01
Normal-vs-Asian
1.261700E-02
Caucasian-vs-AfricanAmerican
9.881000E-01
Caucasian-vs-Asian
4.066500E-02
AfricanAmerican-vs-Asian
1.970390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.382230E-02
Normal-vs-Female
3.186800E-01
Male-vs-Female
7.987600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.003600E-01
Normal-vs-Age(41-60Yrs)
3.737200E-01
Normal-vs-Age(61-80Yrs)
1.030430E-02
Normal-vs-Age(81-100Yrs)
2.686200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.291600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.398200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.080400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.519700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.195980E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.509200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.615200E-01
Normal-vs-Daily Drinker
2.528200E-01
Normal-vs-Weekly Drinker
4.391900E-02
Normal-vs-Occasional Drinker
8.788300E-02
Normal-vs-Social Drinker
1.682230E-01
Non Drinker-vs-Daily Drinker
8.456000E-01
Non Drinker-vs-Weekly Drinker
6.975600E-01
Non Drinker-vs-Occasional Drinker
1.037230E-01
Non Drinker-vs-Social Drinker
1.615220E-01
Daily Drinker-vs-Weekly Drinker
5.911800E-01
Daily Drinker-vs-Occasional Drinker
8.388200E-02
Daily Drinker-vs-Social Drinker
1.435960E-01
Weekly Drinker-vs-Occasional Drinker
3.272800E-01
Weekly Drinker-vs-Social Drinker
4.104600E-01
Occasional Drinker-vs-Social Drinker
9.883000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.943800E-01
Normal-vs-Grade 2
7.217600E-01
Normal-vs-Grade 3
7.187200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.467600E-01
Grade 1-vs-Grade 3
8.245600E-01
Grade 1-vs-Grade 4
3.943800E-01
Grade 2-vs-Grade 3
9.492200E-01
Grade 2-vs-Grade 4
7.217600E-01
Grade 3-vs-Grade 4
7.187200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.852200E-02
Normal-vs-NonDiabetic
2.874000E-01
Diabetic-vs-NonDiabetic
9.871000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.317000E-01
Normal-vs-NoPancreatitis
2.956200E-01
Pancreatitis-vs-NoPancreatitis
2.150800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.601800E-02
Normal-vs-N1
3.206800E-01
N0-vs-N1
6.787000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.451200E-01
Normal-vs-TP53-NonMutant
1.229370E-01
TP53-Mutant-vs-TP53-NonMutant
2.066600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
